对致编辑的题为“多倍体巨型癌细胞：揭示her2靶向治疗中潜在的耐药轴和肿瘤进化”的信的回应。

{"title":"对致编辑的题为“多倍体巨型癌细胞：揭示her2靶向治疗中潜在的耐药轴和肿瘤进化”的信的回应。","authors":"Mark Barok , Narjes Yazdi , Heikki Joensuu","doi":"10.1016/j.canlet.2025.217997","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":9506,"journal":{"name":"Cancer letters","volume":"631 ","pages":"Article 217997"},"PeriodicalIF":10.1000,"publicationDate":"2025-08-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Response to the letter to the editor titled: “Polyploid giant cancer cells: unveiling a latent axis of resistance and tumor evolution in HER2-targeted therapy”\",\"authors\":\"Mark Barok , Narjes Yazdi , Heikki Joensuu\",\"doi\":\"10.1016/j.canlet.2025.217997\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":9506,\"journal\":{\"name\":\"Cancer letters\",\"volume\":\"631 \",\"pages\":\"Article 217997\"},\"PeriodicalIF\":10.1000,\"publicationDate\":\"2025-08-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer letters\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0304383525005671\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0304383525005671","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}